839673-52-8 Usage
Molecular structure
1H-Indole-2-carboxylic acid, 2,3-dihydro-1-[[4-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-4-oxazolyl]methoxy]phenyl]sulfonyl]-, (2R)is a complex organic compound with an indole carboxylic acid core, a sulfonyl group, and various other functional groups.
Stereochemistry
The compound has a specific stereochemistry, with the (2R) configuration indicating the arrangement of atoms in three-dimensional space.
Potential therapeutic applications
This chemical compound is believed to have potential therapeutic applications, possibly as an inhibitor or modulator of biological processes.
Pharmacological activity
The compound is thought to exhibit pharmacological activity, which may be useful in the development of new drugs or therapies.
Further research needed
Despite its potential, more research is required to fully understand the effects and applications of 1H-Indole-2-carboxylic acid, 2,3-dihydro-1-[[4-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-4-oxazolyl]methoxy]phenyl]sulfonyl]-, (2R)in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 839673-52-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,9,6,7 and 3 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 839673-52:
(8*8)+(7*3)+(6*9)+(5*6)+(4*7)+(3*3)+(2*5)+(1*2)=218
218 % 10 = 8
So 839673-52-8 is a valid CAS Registry Number.
839673-52-8Relevant articles and documents
Pparalpha/Gamma Agonists and Processes of Preparing
-
Page/Page column 10, (2008/12/08)
This invention provides a method for preparing compounds having the structure [Formula (I)] wherein L is [Formula (A)] or [Formula (B)] in which R1 is hydrogen or optionally substituted alkyl, n is zero or 1 and m is 1; wherein R is H, halogen, optionally substituted C1-6alkyl or C1-6alkoxy; wherein Z is a bond, O or S; wherein p is an integer from 1 to 5; wherein Q is a bond provided that Z is not a bond when p is 1; or Q is O, S or —C(O)NR6— in which R6 is hydrogen, optionally substituted alkyl or cycloalkyl; or Q is —NR6—, —NR5C(O)NH— or —NR5C(O)O— in which R5 is hydrogen, alkyl or aralkyl provided that p is not 1; wherein W is cycloalkyl, aryl or heterocyclyl; or W and R6 form a 9- to 10-membered bicyclic ring, which may be optionally substituted or may contain oxygen, nitrogen or sulfur.
